GO Capital is a $50 million venture capital fund intended to support young Quebec technology firms in search of financing, particularly firms working in the fields of advanced technologies, information technology, life sciences and telecommunications.
GO Capital investments in the selected firms will match, dollar for dollar, the investments by BDC, bringing the available capital to $100 million.
FIER Partners has undertaken to invest $25 million taken in the new stream of seed funding for technology firms in Go Capital. The remaining capital is being provided by the BDC ($10 million), the Caisse de dépôt et placement du Québec ($10 million), the Solidarity Fund QFL ($3 million) and Fondaction, the CSN’s development fund for co-operation and employment ($2 million).
| Company | Date | Round | Size | Participants |
| Milestone Pharmaceuticals | 6/11 | Unattributed | $13M | 3 |
| Neuralitic Systems | 1/11 | Series B | $8M | 5 |
| Alethia BioTherapeutics | 9/10 | Series A | $9.2M | 4 |
| Leap Medical | 3/10 | Seed | $1.01M | 3 |
| Allostera Pharma | 7/09 | Series C | $15.4M | 4 |
| Neuralitic Systems | 10/08 | Series A | $7M | 3 |
